Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Medical Case Reports
|
March 3, 2023
Chylothorax due to thrombosis of the jugular and subclavian veins in a patient with gastric cancer: a case report
M Ünal, E Ünal, A L T Imholz
The Netherlands Journal of Medicine
|
March 30, 2011
Type B lactic acidosis in solid malignancies
R de Groot, R A Sprenger, A L T Imholz, et al.
Journal of Cancer Research and Clinical Oncology
|
December 30, 2014
HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison
T Koopman, M M Smits, M Louwen, et al.
Journal of Clinical Pharmacy and Therapeutics
|
January 10, 2018
Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations
I R F van Berlo-van de Laar, W J Brummelhuis, A L T Imholz, et al.
British Journal of Cancer
|
April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
E H Lips, L Mulder, A Oonk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy
A M M Oonk, C van Rijn, M M Smits, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 12, 2010
The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients
N Knijn, J Tol, M Koopman, et al.
Clinical Pharmacokinetics
|
May 10, 2023
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer
S E H Detert Oude Weme, L M G Hulskotte, W L Vervenne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2018
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
A G J van Rossum, M Kok, E van Werkhoven, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2022
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study
S L Groenland, R A G van Eerden, K Westerdijk, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Medical Case Reports
|
March 3, 2023
Chylothorax due to thrombosis of the jugular and subclavian veins in a patient with gastric cancer: a case report
M Ünal, E Ünal, A L T Imholz
The Netherlands Journal of Medicine
|
March 30, 2011
Type B lactic acidosis in solid malignancies
R de Groot, R A Sprenger, A L T Imholz, et al.
Journal of Cancer Research and Clinical Oncology
|
December 30, 2014
HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison
T Koopman, M M Smits, M Louwen, et al.
Journal of Clinical Pharmacy and Therapeutics
|
January 10, 2018
Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations
I R F van Berlo-van de Laar, W J Brummelhuis, A L T Imholz, et al.
British Journal of Cancer
|
April 6, 2013
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
E H Lips, L Mulder, A Oonk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 24, 2012
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy
A M M Oonk, C van Rijn, M M Smits, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 12, 2010
The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients
N Knijn, J Tol, M Koopman, et al.
Clinical Pharmacokinetics
|
May 10, 2023
Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer
S E H Detert Oude Weme, L M G Hulskotte, W L Vervenne, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2018
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
A G J van Rossum, M Kok, E van Werkhoven, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2022
Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study
S L Groenland, R A G van Eerden, K Westerdijk, et al.
Page
of 2